検索結果

塞症に伴う黄斑浮腫 ・病的近視における脈絡膜新生血管 ・糖尿病黄斑浮腫 承 認 条 件 医薬品リスク管理計画を策定の上、適切に実施すること。 備 考 令和 5 年 1 月 11 日に、糖尿病黄斑浮腫の効能又は効果、用法及び用量について 承認事項一部変更承認を取得。 令和 5 年 9 月 27 日に、網膜静脈閉塞症に伴う黄斑浮腫の効能又は効果、用法及 び用量について承認事項一部変更承認を取得。2 ...

·····················································································7 V．治療に関する項目 1．効能又は効果······························································································...

·····················································································7 V．治療に関する項目 1．効能又は効果······························································································...

·····················································································7 V．治療に関する項目 1．効能又は効果······························································································...

·····················································································7 V．治療に関する項目 1．効能又は効果······························································································...